The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Tom Brady's $200 million investment helped AI healthcare startup eMed cross $2 billion valuation.
DexCare Acquires AI Care Coordination Platform Mila Health to Unify Patient Access and Conversational Scheduling
What You Should Know Patient access and navigation leader DexCare, Inc. announced the acquisition of Mila Health, an AI-driven care coordination company whose conversational agents autonomously call, text, and chat with patients to manage scheduling, pre-visit preparation, and post-discharge follow-ups. The transaction represents DexCare’s second corporate acquisition, building on its 2022 pu…
Radiopharmaceutical Dealmaking Continues With Telix’s $1.65B ITM Acquisition
Telix Pharmaceuticals is acquiring Isotope Technologies Munich, or ITM, in a $1.65 billion stock deal that will create a radiopharmaceuticals company with greater global scale. ITM’s lead pipeline asset is in late-stage development for a type of gastrointestinal cancer, where it could compete against Novartis and Curium Pharma products. The post Radiopharmaceutical Dealmaking Continues With T…
Follow the full firehose on the HTC Wire, refreshed automatically every day.